EXAMPTIA 40MG/0.8ML INJECTION | Adalimumab Pre-Filled Syringe
EXAMPTIA 40MG/0.8ML INJECTION contains Adalimumab 40mg, a TNF inhibitor monoclonal antibody therapy used for autoimmune conditions requiring targeted inflammation control under specialist medical supervision.
EXAMPTIA 40MG/0.8ML INJECTION
EXAMPTIA 40MG/0.8ML INJECTION (ADALIMUMAB 40MG): Comprehensive Guide and Benefits
Introduction to EXAMPTIA 40MG/0.8ML INJECTION (ADALIMUMAB 40MG)
EXAMPTIA 40MG/0.8ML: A Targeted Biologic Immunotherapy
EXAMPTIA 40MG/0.8ML INJECTION contains Adalimumab 40mg, a fully human monoclonal antibody belonging to the Tumor Necrosis Factor (TNF) inhibitor class. It is a targeted biological therapy designed to help control excessive inflammatory responses involved in various autoimmune disorders.
Adalimumab works by selectively binding to Tumor Necrosis Factor-alpha (TNF-α), a protein involved in inflammation. By blocking TNF activity, it helps reduce inflammatory processes associated with immune-mediated diseases.
EXAMPTIA 40MG/0.8ML is supplied as a pre-filled syringe containing 0.8ml solution and is administered by subcutaneous injection under the supervision of a qualified healthcare professional. It is a prescription-only biological medicine requiring appropriate medical monitoring.
Drug Class
Therapeutic Class: Immunomodulatory Therapy
Drug Class: TNF-Alpha Inhibitor
Biological Class: Monoclonal Antibody (Biologic DMARD)
Generic Name: Adalimumab 40mg/0.8ml
Key Benefits of EXAMPTIA 40MG/0.8ML INJECTION (ADALIMUMAB 40MG)
Helps regulate excessive inflammatory immune responses.
Supports management of autoimmune inflammatory conditions.
Provides targeted TNF-alpha inhibition.
Helps improve disease control in suitable patients.
Offers convenient administration through a pre-filled syringe.
How EXAMPTIA 40MG/0.8ML INJECTION Works
Adalimumab in EXAMPTIA acts by targeting TNF-alpha, an inflammatory cytokine that plays an important role in immune system activation.
The mechanism includes:
Binding to TNF-alpha molecules.
Preventing TNF interaction with cell receptors.
Reducing inflammatory signalling pathways.
Helping decrease immune-mediated tissue inflammation.
This targeted approach helps control inflammation associated with autoimmune disorders.
Usage Instructions for EXAMPTIA 40MG/0.8ML INJECTION
EXAMPTIA 40MG/0.8ML should be used only as prescribed by a healthcare professional.
It is administered as a subcutaneous injection according to the prescribed schedule.
The pre-filled syringe should be handled as instructed by medical professionals.
Do not shake the syringe.
Follow regular medical monitoring recommendations.
Do not stop or change treatment without consulting your doctor.
Medicinal Advantages of EXAMPTIA 40MG/0.8ML INJECTION
Provides selective inhibition of TNF-mediated inflammation.
Supports long-term management of inflammatory autoimmune disorders.
Helps control immune system overactivity.
Offers targeted biological therapy compared with conventional immunosuppressive approaches.
Provides ready-to-use injectable formulation.
NOTE: EXAMPTIA 40MG/0.8ML INJECTION is a prescription biologic therapy and should only be used under specialist medical supervision.
Off-Label Uses of EXAMPTIA 40MG/0.8ML INJECTION
Healthcare professionals may consider Adalimumab therapy for additional inflammatory conditions based on individual patient assessment and medical guidelines.
Possible specialist-guided applications include:
Selected inflammatory autoimmune disorders.
Specialist-directed immunomodulatory treatment protocols.
Individualized biologic therapy plans.
Disclaimer: Off-label use should only be considered by qualified healthcare professionals.
Expert Advice for Optimal Use
Complete required screening tests before starting therapy as advised by your doctor.
Maintain regular follow-up appointments.
Inform your healthcare provider about infections or ongoing illnesses.
Follow the injection schedule carefully.
Do not share pre-filled syringes with others.
Precautions
Infections
Adalimumab affects immune system activity. Inform your doctor about current infections or previous serious infections before starting treatment.
Tuberculosis Screening
Appropriate screening for tuberculosis may be recommended before and during therapy.
Liver & Kidney Function
Inform your healthcare provider about existing liver or kidney conditions before treatment.
Pregnancy & Breastfeeding
Consult your doctor before using EXAMPTIA during pregnancy or breastfeeding.
Existing Medical Conditions
Inform your physician about heart failure, neurological disorders, immune system problems, or previous allergic reactions before receiving therapy.
Storage Instructions
Store refrigerated at 2°C to 8°C.
Do not freeze.
Protect from direct light.
Keep the pre-filled syringe in the original carton.
Do not shake.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is EXAMPTIA 40MG/0.8ML INJECTION used for?
A: EXAMPTIA contains Adalimumab and is used for managing various autoimmune inflammatory conditions under specialist supervision.
Q: What is the active ingredient in EXAMPTIA 40MG/0.8ML?
A: It contains Adalimumab 40mg in a 0.8ml pre-filled syringe.
Q: What type of medicine is EXAMPTIA?
A: It is a monoclonal antibody biologic therapy and TNF inhibitor.
Q: How does EXAMPTIA work?
A: It blocks TNF-alpha activity, helping reduce inflammatory immune responses.
Q: How is EXAMPTIA 40MG/0.8ML administered?
A: It is administered as a subcutaneous injection using a pre-filled syringe under medical guidance.
Q: Is EXAMPTIA 40MG/0.8ML prescription-only?
A: Yes. It is a prescription biological medicine requiring specialist supervision.
Product Tags
EXAMPTIA 40MG/0.8ML Injection, Adalimumab 40mg Injection, TNF Inhibitor Therapy, Monoclonal Antibody Injection, Biologic DMARD, Autoimmune Disease Treatment, Rheumatoid Arthritis Therapy, Psoriasis Injection, Crohn's Disease Therapy, Ulcerative Colitis Treatment, Pre Filled Syringe Injection, Immunomodulatory Medicine, Prescription Biologic Therapy, Zydus Adalimumab Injection.
